Benlysta 1 Vial 120 mg

Benlysta is the first and only FDA-approved medicine specifically designed to treat lupus. It is a biologic therapy that works to reduce the body’s abnormal immune response from lupus, providing relief from symptoms and helping patients manage their condition. Benlysta works by targeting a specific protein known as B-cell activating factor (BAFF), which plays a role in the abnormal immune response in lupus. This helps to reduce inflammation and organ damage, as well as improve the quality of life for those living with lupus. Benlysta is a once-monthly intravenous infusion, and is generally well-tolerated by most patients with few side effects. When taken as prescribed, Benlysta can help to reduce fatigue, pain, and other lupus-related symptoms, allowing patients to better manage their condition and live a more active and healthy life.